Stefan Braam, Ph.D., CEO

April 20 | 11:30am | Gaudi 2 Ballroom

Leiden, Netherlands


In-Person Presentation

Ncardia is a globally operating human-induced pluripotent stem cell (iPSC) technology company, with facilities in Europe and North America. Our mission is to enable biopharmaceutical companies in drug discovery and cell therapy to bring better therapies to patients faster by integrating human iPSC technologies in their development process. We partner with cell therapy clients to co-develop novel therapeutics that utilize iPSC technologies. Our 10+ years of experience in the development, commercial manufacture, and characterization of iPSC-derived cell models provides our customers with a manufacturing process based on a deep knowledge of stem cell biology.

By using this website you agree to accept our Privacy Policy and Terms & Conditions